127 related articles for article (PubMed ID: 12567164)
41. Ligase chain reaction for Chlamydia trachomatis detection in urine specimens from symptomatic and asymptomatic men.
Peng XB; Zeng K
Di Yi Jun Yi Da Xue Xue Bao; 2004 May; 24(5):485-8. PubMed ID: 15151813
[TBL] [Abstract][Full Text] [Related]
42. Screening for genital chlamydia infection: DNA amplification techniques should be the test of choice.
Harindra V; Underhill G; Tobin JM
Int J STD AIDS; 2003 Nov; 14(11):723-6. PubMed ID: 14624732
[TBL] [Abstract][Full Text] [Related]
43. Cost-effectiveness of screening swab or urine specimens for Chlamydia trachomatis from young Canadian women in Ontario.
Goeree R; Jang D; Blackhouse G; Chong S; Mahony J; Sellors J; Foy A; Chernesky M
Sex Transm Dis; 2001 Dec; 28(12):701-9. PubMed ID: 11725225
[TBL] [Abstract][Full Text] [Related]
44. Direct and indirect effects of screening for Chlamydia trachomatis on the prevention of pelvic inflammatory disease: a mathematical modeling study.
Herzog SA; Heijne JC; Scott P; Althaus CL; Low N
Epidemiology; 2013 Nov; 24(6):854-62. PubMed ID: 24076992
[TBL] [Abstract][Full Text] [Related]
45. [Development of a gap ligase chain reaction for detection of Chlamydia trachomatis in newborn infants].
Wei H; Wu SX; Yu JL; Yang J; Liu GX
Zhonghua Er Ke Za Zhi; 2003 Aug; 41(8):578-81. PubMed ID: 14744376
[TBL] [Abstract][Full Text] [Related]
46. Comparison of nucleic acid amplification tests and culture techniques in the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in victims of suspected child sexual abuse.
Kellogg ND; Baillargeon J; Lukefahr JL; Lawless K; Menard SW
J Pediatr Adolesc Gynecol; 2004 Oct; 17(5):331-9. PubMed ID: 15581779
[TBL] [Abstract][Full Text] [Related]
47. Should asymptomatic men be included in chlamydia screening programs? Cost-effectiveness of chlamydia screening among male and female entrants to a national job training program.
Blake DR; Quinn TC; Gaydos CA
Sex Transm Dis; 2008 Jan; 35(1):91-101. PubMed ID: 18217229
[TBL] [Abstract][Full Text] [Related]
48. Screening for Chlamydia trachomatis in asymptomatic women in Hungary. An epidemiological and cost-effectiveness analysis.
Nyári T; Nyári C; Woodward M; Mészáros G; Deák J; Nagy E; Kovács L
Acta Obstet Gynecol Scand; 2001 Apr; 80(4):300-6. PubMed ID: 11264602
[TBL] [Abstract][Full Text] [Related]
49. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials.
Gottlieb SL; Xu F; Brunham RC
Sex Transm Dis; 2013 Feb; 40(2):97-102. PubMed ID: 23324973
[TBL] [Abstract][Full Text] [Related]
50. Urine-based testing for Chlamydia trachomatis using polymerase chain reaction, leucocyte esterase and urethral and cervical smears.
Coble BI; Nordahl-Akesson E; Vinnerberg A; Kihlström E
Scand J Clin Lab Invest; 2006; 66(4):269-77. PubMed ID: 16777755
[TBL] [Abstract][Full Text] [Related]
51. LCR testing for gonorrhoea and chlamydia in population surveys and other screenings of low prevalence populations: coping with decreased positive predictive value.
Zenilman JM; Miller WC; Gaydos C; Rogers SM; Turner CF
Sex Transm Infect; 2003 Apr; 79(2):94-7. PubMed ID: 12690126
[TBL] [Abstract][Full Text] [Related]
52. Optimised sample DNA preparation for detection of Chlamydia trachomatis in synovial tissue by polymerase chain reaction and ligase chain reaction.
Freise J; Gérard HC; Bunke T; Whittum-Hudson JA; Zeidler H; Köhler L; Hudson AP; Kuipers JG
Ann Rheum Dis; 2001 Feb; 60(2):140-5. PubMed ID: 11156547
[TBL] [Abstract][Full Text] [Related]
53. Chlamydia trachomatis in cervical and vaginal swabs and urine specimens from women undergoing termination of pregnancy.
Renton A; Thomas BM; Gill S; Lowndes C; Taylor-Robinson D; Patterson K
Int J STD AIDS; 2006 Jul; 17(7):443-7. PubMed ID: 16820072
[TBL] [Abstract][Full Text] [Related]
54. Chlamydia trachomatis infections in female military recruits.
Gaydos CA; Howell MR; Pare B; Clark KL; Ellis DA; Hendrix RM; Gaydos JC; McKee KT; Quinn TC
N Engl J Med; 1998 Sep; 339(11):739-44. PubMed ID: 9731090
[TBL] [Abstract][Full Text] [Related]
55. Detection of Chlamydia trachomatis cervical infection by urine tests among adolescents clinics.
Beck-Sague CM; Farshy CE; Jackson TK; Guillory L; Edelkind D; Bullard JC; Urdez EA; Jones B; Francis K; Sievert A; Morse SA; Black CM
J Adolesc Health; 1998 Mar; 22(3):197-204. PubMed ID: 9502006
[TBL] [Abstract][Full Text] [Related]
56. What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial.
Aghaizu A; Adams EJ; Turner K; Kerry S; Hay P; Simms I; Oakeshott P
Sex Transm Infect; 2011 Jun; 87(4):312-7. PubMed ID: 21444333
[TBL] [Abstract][Full Text] [Related]
57. Screening for chlamydia in general practice.
Heal C; Jones B; Veitch C; Lamb S; Hodgens S; Browning S; Butler H; Carey M
Aust Fam Physician; 2002 Aug; 31(8):779-82. PubMed ID: 12189675
[TBL] [Abstract][Full Text] [Related]
58. Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy.
Blackwell AL; Thomas PD; Wareham K; Emery SJ
Lancet; 1993 Jul; 342(8865):206-10. PubMed ID: 8100930
[TBL] [Abstract][Full Text] [Related]
59. Cost effectiveness of testing for chlamydial infections in asymptomatic women.
Buhaug H; Skjeldestad FE; Backe B; Dalen A
Med Care; 1989 Aug; 27(8):833-41. PubMed ID: 2502694
[TBL] [Abstract][Full Text] [Related]
60. [Importance of regular screening for genital chlamydiosis in adolescents].
Pospísil L; Stroblová H; Pejcoch M; Anton M; Pohanka M; Canderle J; Vĕzník Z; Medková Z
Ceska Gynekol; 2003 Mar; 68(2):68-71. PubMed ID: 12749172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
